Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Apremilast in Alopecia Areata
NCT05926882Phase 4Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Aug 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast in alopecia areata, sponsored by Jinnah Postgraduate Medical Centre. Started Aug 2022; status: completed.
02
Drugs
apremilast
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT05926882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05926882.